Loomis, Sayles & Company’s Progyny PGNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$31.2M Buy
1,080,928
+92,538
+9% +$2.07M 0.04% 178
2026
Q1
$16.8M Buy
988,390
+212,810
+27% +$4.56M 0.02% 264
2025
Q4
$19.9M Buy
+775,580
New +$17.8M 0.02% 235
2024
Q3
Sell
-901,974
Closed -$25.8M 735
2024
Q2
$25.8M Sell
901,974
-246,370
-21% -$7.42M 0.04% 214
2024
Q1
$43.8M Buy
1,148,344
+53,796
+5% +$2.03M 0.06% 144
2023
Q4
$40.7M Buy
1,094,548
+84,270
+8% +$2.83M 0.06% 146
2023
Q3
$34.4M Buy
1,010,278
+63,136
+7% +$2.38M 0.06% 158
2023
Q2
$37.3M Buy
+947,142
New +$34.2M 0.06% 152

Other funds holding PGNY

Loomis, Sayles & Company's PGNY Position: Q2 2026 in Review

Loomis, Sayles & Company increased its Progyny (PGNY) stake by 9.4% in Q2 2026, buying an estimated $2.07M and bringing the position to 1,080,928 shares worth $31.2M. The position accounts for 0.04% of the portfolio, ranked #178.

Loomis, Sayles & Company first reported a position in PGNY in Q2 2023 and has held it in 8 quarters since. The position peaked at $43.8M in Q1 2024. 311 funds tracked by Wall St. Rank hold PGNY as of Q2 2026.

  • Loomis, Sayles & Company held 1,080,928 shares of Progyny worth $31.2M as of Q2 2026.
  • Loomis, Sayles & Company bought 92,538 Progyny shares in Q2 2026, an estimated $2.07M.
  • Progyny made up 0.04% of Loomis, Sayles & Company's portfolio in Q2 2026, its #178 holding.
  • Loomis, Sayles & Company first reported a position in Progyny in Q2 2023 and has held it in 8 quarters since.
  • Loomis, Sayles & Company's Progyny position peaked at $43.8M in Q1 2024.
  • 311 funds tracked by Wall St. Rank held Progyny as of Q2 2026.

Based on Loomis, Sayles & Company's 13F filing for Q2 2026, filed 14 Aug 2026.